An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma.

Authors :: Zhang, Chaoqi
Zhang, Guochao
Sun, Nan
Zhang, Zhen
Xue, Liyan
Zhang, Zhihui
Yang, Haijun
Luo, Yuejun
Zheng, Xiaoli
Zhang, Yonglei
Yuan, Yufen
Lei, Ruixue
Yang, Zhaoyang
Zheng, Bo
Wang, Le
Che, Yun
Wang, Feng
Wang, Sihui
Gao, Shugeng
Xue, Qi
Source :: Signal Transduction & Targeted Therapy; 9/4/2020, pN.PAG-N.PAG, 1p
Publication Year :: 2020

Full Text Access

Tools